LEXIVA

Product NDC
49702-207
11-digit product format
497020207
Labeler code
49702
Product ID
49702-207_05c0714d-c373-4321-89ac-0acb18394db1
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
fosamprenavir calcium
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
ViiV Healthcare Company
Application
NDA021548
Marketing category
NDA
Marketing start
2010-10-04
Marketing end
0000-00-00
Substance
FOSAMPRENAVIR CALCIUM
Active strength
700 mg/1
Pharmacologic classes
Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], P-Glycoprotein Inducers [MoA], Protease Inhibitor [EPC]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
30518cdc-4e65-0105-bf49-967999bc76dbProduct name320200506

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
49702-207-18EA - Each49702-207b57758fd-80c6-41d2-93fe-caba6fb278c912012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
FOSAMPRENAVIR CALCIUMACTIVE INGREDIENTID1GU2627NLEXIVA (FOSAMPRENAVIR CALCIUM) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]1
AMPRENAVIRACTIVE MOIETY5S0W860XNRLEXIVA (FOSAMPRENAVIR CALCIUM) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]1
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61ULEXIVA (FOSAMPRENAVIR CALCIUM) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]1
COLLOIDAL SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4LEXIVA (FOSAMPRENAVIR CALCIUM) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]1
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48LEXIVA (FOSAMPRENAVIR CALCIUM) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]1
FERRIC OXIDE REDINACTIVE INGREDIENT1K09F3G675LEXIVA (FOSAMPRENAVIR CALCIUM) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]1
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WOLEXIVA (FOSAMPRENAVIR CALCIUM) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]1
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30LEXIVA (FOSAMPRENAVIR CALCIUM) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]1
POVIDONE K30INACTIVE INGREDIENTU725QWY32XLEXIVA (FOSAMPRENAVIR CALCIUM) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]1
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPLEXIVA (FOSAMPRENAVIR CALCIUM) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]1
TRIACETININACTIVE INGREDIENTXHX3C3X673LEXIVA (FOSAMPRENAVIR CALCIUM) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]1

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
402109fosamprenavir calcium 700 MG Oral TabletPSNb919bb7e-75f8-4df4-924c-54e829be06071
402110Lexiva 700 MG Oral TabletPSNb919bb7e-75f8-4df4-924c-54e829be06071
402110fosamprenavir 700 MG Oral Tablet [Lexiva]SBDb919bb7e-75f8-4df4-924c-54e829be06071
402109fosamprenavir 700 MG Oral TabletSCDb919bb7e-75f8-4df4-924c-54e829be06071
402109fosamprenavir (as fosamprenavir calcium) 700 MG (amprenavir 600 MG) Oral TabletSYb919bb7e-75f8-4df4-924c-54e829be06071
402110Lexiva (as fosamprenavir calcium) 700 MG (amprenavir 600 MG) Oral TabletSYb919bb7e-75f8-4df4-924c-54e829be06071
402110Lexiva 700 MG Oral TabletSYb919bb7e-75f8-4df4-924c-54e829be06071

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
49702-207-184970202071860 TABLET, FILM COATED in 1 BOTTLE (49702-207-18) 2010-10-040000-00-00NoNoCurrent